The US Food and Drug Administration (FDA) has approved generic versions of Gilenya, a multiple sclerosis (MS) medication.

A recent study found a possible link between organic solvents and increased multiple sclerosis (MS) risk in people with genes that make them more susceptible to developing the condition.

Mothers who breastfeed their children longer may be less likely to develop multiple sclerosis (MS), according to a new study.

When diseases occur during childbearing years, it’s not always possible to stop treatment for the disease. Doctors and patients must balance the concern for the drug's possible effects on pregnancy with the concern for disease relapse.

Many women do not seek medical care for urinary incontinence as they may not feel like it is a priority medical issue or they may feel too embarrassed to address it. Addressing the problem can help patients improve their quality of life, especially for those who are living with other medical conditions such as multiple sclerosis (MS).

In search of the cause of multiple sclerosis (MS), researchers are currently examining the genetic environment in which the disease arises.